CoChat

In-vitro interaction of l-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability?

Niehues, Michael, Hensel, Andreas · 2009 · Journal of Pharmacy and Pharmacology
Cited by 56

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Objectives: Recent investigations on the pharmacokinetics of levodopa (l-dopa) indicated that the presence of Helicobacter pylori in patients with Parkinson's disease, orally treated with l-dopa, influences the absorption of this compound, which consequently leads to decreased plasma levels. Therefore this work aims to study a potential in-vitro interaction of l-dopa with H. pylori and its surface adhesins. Methods: Solutions containing l-dopa of different concentrations were incubated with H. pylori at different bacterial densities and time intervals. Free l-dopa was quantified from the incubation supernatants by HPLC. A flow cytometric assay with fluorescence labelled H. pylori was used to investigate the influence of l-dopa on the bacterial adhesion of H. pylori: FITC-labelled bacteria were pre-incubated with l-dopa, followed by incubation with gastric epithelial cells (AGS cells) and FACS quantification of adhering bacteria. Key findings: Evaluation of time- and concentration-dependent incubation experiments indicated a significant decrease in l-dopa concentrations when coming into contact with H. pylori. The reduction in l-dopa concentrations was determined as 47 to 12%, referred to the initial starting concentration, with time-dependency and dependency of the H. pylori density. FITC-labelled H. pylori, pre-incubated with differing l-dopa concentrations, were shown to have a significantly reduced bacterial adhesion to AGS cells, with a maximum reduction of 22 ± 9%. These results demonstrate a direct interaction of l-dopa with the outer membrane proteins of H. pylori responsible for the adhesion to gastric epithelial cells. By this interaction the unbound l-dopa concentration in bacterial suspension was strongly reduced. Conclusions: This study suggests a potential in-vitro interaction of l-dopa with H. pylori adhesins, confirming the clinical changes found in pharmacokinetics of l-dopa therapy by H. pylori-positive patients with Parkinson's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1211/jpp.61.10.0005

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 24

  1. Blaser, 1999, Dynamics of Helicobacter pylori colonization in relation to the host response, Proc Natl Acad Sci USA, 96, 8359, 10.1073/pnas.96.15.8359 · doi:10.1073/pnas.96.15.8359
  2. Strömberg, 2003, Increased frequency of activated T-cells in the Helicobacter pylori-infected antrum and duodenum, FEMS, 36, 159
  3. Evans, 1993, Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori, J Bacteriol, 175, 674, 10.1128/jb.175.3.674-683.1993 · DOI · Paper page
  4. Simon, 1997, Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligo-saccharides, Infect Immun, 65, 750, 10.1128/iai.65.2.750-757.1997 · DOI · Paper page
  5. Boren, 1993, Attachment of H. pylori to human gastric epithelium mediated by blood group antigens, Science, 262, 1892, 10.1126/science.8018146 · DOI · Paper page
  6. Pietroiusti, 2008, Helicobacter pylori interference with micronutrients and orally administered drugs: a new mechanism explaining its role in extragastric disorders, Mini Rev Med Chem, 8, 135, 10.2174/138955708783498177 · DOI
  7. Pierantozzi, 2001, Helicobacter pylori induced reduction of acute levodopa absorption in Parkinson's disease patients, Ann Neurol, 50, 686, 10.1002/ana.1267 · DOI
  8. Pierantozzi, 2001, Reduced L-Dopa absorption and increased clinical fluctuations in Helicobacter pylori infected Parkinson's disease patients, Neurol Sci, 22, 89, 10.1007/s100720170061 · DOI
  9. Kurlan, 1988, Duodenal and gastric delivery of levodopa in parkinsonism, Ann Neurol, 23, 589, 10.1002/ana.410230611 · DOI · Paper page
  10. Hamlet, 1999, Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers, Gastroenterology, 116, 259, 10.1016/S0016-5085(99)70121-6 · DOI
  11. Calam, 1999, Helicobacter pylori modulation of gastric acid, Yale J Biol Med, 72, 195
  12. Drake, 1998, Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: relation to gastric mucosal ascorbic acid concentration and effect of H. pylori eradication, Gut, 42, 768, 10.1136/gut.42.6.768 · DOI · Paper page
  13. Davies, 1994, Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo, Gut, 35, 179, 10.1136/gut.35.2.179 · DOI · Paper page
  14. Kankkunen, 2002, Improved stability and release control of levodopa and metaraminol using ionexchange fibers and transdermal iontophoresis, Eur J Pharm Sci, 16, 273, 10.1016/S0928-0987(02)00113-6 · DOI
  15. Lengsfeld, 2004, Glycosylated compounds from Okra inhibit adhesion of Helicobacter pylori to human gastric mucosa, J Agric Food Chem, 52, 1495, 10.1021/jf030666n · DOI · Paper page
  16. Lengsfeld, 2004, High molecular weight polysaccharides from black currant seed inhibit adhesion of Helicobacter pylori to human gastric mucosa, Planta Med, 70, 620, 10.1055/s-2004-827184 · doi:10.1055/s-2004-827184
  17. Wittschier, 2007, Large molecules as antiadhesive compounds against pathogens, J Pharm Pharmacol, 59, 777, 10.1211/jpp.59.6.0004 · DOI
  18. Icatlo Jnr, 1998, Affinity purification of Helicobacter pylori urease. relevance to gastric mucin adherence by urease protein, J Biol Chem, 273, 18230
  19. Evans, 2000, Helicobacter pylori adhesins: review and perspectives, Helicobacter, 5, 183, 10.1046/j.1523-5378.2000.00029.x · DOI
  20. Odenbreit, 2005, Adherence properties of Helicobacter pylori: impact on pathogenesis and adaptation to the host, Int J Med Microbiol, 295, 317, 10.1016/j.ijmm.2005.06.003 · DOI
  21. Lengsfeld, 2004, Isolierung und Charakterisierung bioaktiver Polysaccharide und Extrakte aus Okra (Abelmoschi esculenti fructus) und deren Einsatz in physiologischen Testsystemen mit Relevenz für den Gastrointestinaltrakt
  22. Mysore, 1999, Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound, Gastro-enterology, 117, 1316, 10.1016/S0016-5085(99)70282-9 · DOI · Paper page
  23. De Jonge, 2004, Role of the Helicobacter pylori outer-membrane proteins AlpA and AlpB in colonization of the guinea pig stomach, J Med Microbiol, 53, 375, 10.1099/jmm.0.45551-0 · DOI
  24. Krygowska-Wajs, 2009, Evaluation of gastric emptying in familial and sporadic Parkinson disease, Parkinson Relat Disord, 10.1016/j.parkreldis.2009.04.003 · DOI

Cited by

See all 56

Metadata

Authors
Niehues, M., & Hensel, A.
Venue
Journal of Pharmacy and Pharmacology
Published
2009-10-01
Volume
61
Issue
10
Pages
1303-1307
ISSN
  • 0022-3573 (ISSN-L)
  • 2042-7158
OpenAlex
W2008664022
Cited by
56
References
3
FWCI
2.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.